T
Tenaya Therapeutics, Inc. (TNYA)
NMS – Real Time Price. Currency in USD
0.72
+0.01 (1.06%)
At close: Jun 26, 2026, 4:00 PM EDT
0.73
+0.01 (1.60%)
After-hours: Jun 26, 2026, 7:27 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
0.72
+0.01 (1.06%)
At close: Jun 26, 2026, 4:00 PM EDT
0.73
+0.01 (1.60%)
After-hours: Jun 26, 2026, 7:27 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $80.9M significantly exceed its total debt $10.1M, ensuring strong financial flexibility
Total current assets $96.6M exceed Total current liabilities $16.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$19.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.75 | 6.05 | 10 | |
| Quick ratio | 5.75 | 5.63 | 10 | |
| Debt to Equity | 0.10 | 0.30 | 9.0 | |
| Debt to Assets | 0.07 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | 225K |
| Gross Profit | -9M | -9M | -8M | -8M | -7M |
| Operating Income | -126M | -131M | -116M | -93M | -86M |
| Net Income | -124M | -124M | -111M | -91M | -83M |
| EBITDA | -117M | -123M | -107M | -85M | -78M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 54.08 | 5.5 |
| Next quarter | N/A | 17.86 | 5.0 |
| Current year | N/A | 32.45 | 5.5 |
| Next year | -100 | -4.12 | 1.0 |
| Weighted average score | 4.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 4.48 | 25 | -37.39 | 6.3 |
| Y/Y | 999 | 28.26 | 62.5 | 18.09 | 9.8 |
| 3y average | 999 | 9.53 | 38.7 | 17.85 | 8.8 |
| 5y average | 999 | -26.16 | 37.2 | -16.4 | 5.5 |
| Weighted average score | 7.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |